EGCG: A Compound in Green Tea to Treat Alzheimer’s Disease - Aleksandras Lotuzas

Year
2026
Organisation
Summary

This research develops a method to deliver EGCG, a green tea compound known to break apart Alzheimer's-related protein tangles, into the brain. By chemically attaching EGCG to a carrier that can cross the brain's protective barrier, the project aims to create a potential therapeutic strategy for slowing memory loss and disease progression.